ANGLE plc 47.7% potential upside indicated by Berenberg Bank

ANGLE plc with ticker (LON:AGL) now has a potential upside of 47.7% according to Berenberg Bank.



Berenberg Bank set a target price of 195 GBX for the company, which when compared to the ANGLE plc share price of 102 GBX at opening today (18/05/2022) indicates a potential upside of 47.7%. Trading has ranged between 72 (52 week low) and 144 (52 week high) with an average of 574,550 shares exchanging hands daily. The market capitalisation at the time of writing is £239,852,676.

ANGLE plc is a United Kingdom-based specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. The Company’s lead product is the Parsortix cell separation system, which captures very rare cells from the blood. This includes circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The Company’s translational research includes ovarian cancer, breast cancer, prostate cancer and small cell lung cancer.